Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
236 | 3 | PROSTATE CANCER//PROSTATIC NEOPLASMS//UROL | 47933 |
282 | 2 | PROSTATE CANCER//PROSTATE//ANDROGEN RECEPTOR | 19095 |
25114 | 1 | SELECTIVE ANDROGEN RECEPTOR MODULATOR//SARM//SARMS | 313 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | SELECTIVE ANDROGEN RECEPTOR MODULATOR | authKW | 1993679 | 11% | 60% | 33 |
2 | SARM | authKW | 1518102 | 9% | 54% | 28 |
3 | SARMS | authKW | 1359335 | 6% | 75% | 18 |
4 | PREVENT DOPING | address | 528660 | 12% | 14% | 38 |
5 | AR ANTAGONIST | authKW | 460300 | 3% | 57% | 8 |
6 | SELECTIVE ANDROGEN RECEPTOR MODULATORS SARMS | authKW | 402769 | 1% | 100% | 4 |
7 | PURE ANTAGONIST | authKW | 268510 | 1% | 67% | 4 |
8 | DOPING PREVENT | address | 258916 | 2% | 43% | 6 |
9 | ANDROGEN RECEPTOR ANTAGONISTS | authKW | 205570 | 2% | 29% | 7 |
10 | CASTRATION RESISTANT PROSTATE CANCERS | authKW | 201384 | 1% | 100% | 2 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 6790 | 43% | 0% | 136 |
2 | Chemistry, Organic | 850 | 24% | 0% | 76 |
3 | Pharmacology & Pharmacy | 475 | 24% | 0% | 76 |
4 | Biochemical Research Methods | 327 | 12% | 0% | 36 |
5 | Chemistry, Analytical | 188 | 12% | 0% | 37 |
6 | Spectroscopy | 158 | 7% | 0% | 21 |
7 | Endocrinology & Metabolism | 152 | 10% | 0% | 30 |
8 | Biochemistry & Molecular Biology | 49 | 15% | 0% | 46 |
9 | Crystallography | 16 | 3% | 0% | 8 |
10 | Toxicology | 7 | 2% | 0% | 7 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PREVENT DOPING | 528660 | 12% | 14% | 38 |
2 | DOPING PREVENT | 258916 | 2% | 43% | 6 |
3 | DERMATOL BIOL | 181244 | 1% | 60% | 3 |
4 | NEW LEADS DISCOVERY | 113269 | 2% | 19% | 6 |
5 | ANALYT CHEM ENVIRONM CHEM | 100692 | 0% | 100% | 1 |
6 | CORP MKT OFF | 100692 | 0% | 100% | 1 |
7 | GROTON NEW LONDON | 100692 | 0% | 100% | 1 |
8 | M DISCOVERY | 100692 | 0% | 100% | 1 |
9 | METAB VIRAL DRUG DISCOVERY | 100692 | 0% | 100% | 1 |
10 | NORRIE POINT STN | 100692 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DRUG TESTING AND ANALYSIS | 16196 | 4% | 1% | 13 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 9383 | 16% | 0% | 49 |
3 | JOURNAL OF MEDICINAL CHEMISTRY | 5971 | 12% | 0% | 36 |
4 | EUROPEAN JOURNAL OF MASS SPECTROMETRY | 2507 | 2% | 1% | 5 |
5 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1858 | 4% | 0% | 13 |
6 | EXPERT OPINION ON THERAPEUTIC PATENTS | 1579 | 2% | 0% | 6 |
7 | RAPID COMMUNICATIONS IN MASS SPECTROMETRY | 1331 | 4% | 0% | 11 |
8 | ACS MEDICINAL CHEMISTRY LETTERS | 1083 | 1% | 0% | 4 |
9 | MEDCHEMCOMM | 1068 | 1% | 0% | 4 |
10 | BIOORGANIC & MEDICINAL CHEMISTRY | 1064 | 4% | 0% | 12 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |